We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+1.27%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$278M
AUM Growth
-$148M
Cap. Flow
-$149M
Cap. Flow %
-53.67%
Top 10 Hldgs %
51.03%
Holding
53
New
6
Increased
12
Reduced
16
Closed
15

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$8.49M
2
COR icon
Cencora
COR
+$6.02M
3
A icon
Agilent Technologies
A
+$4.89M
4
BIIB icon
Biogen
BIIB
+$4.34M
5
BRKR icon
Bruker
BRKR
+$3.01M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$28.5M
2
CRL icon
Charles River Laboratories
CRL
+$6.77M
3
INSP icon
Inspire Medical Systems
INSP
+$5.91M
4
ABT icon
Abbott
ABT
+$5.68M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$5.02M

Sector Composition

Rank Sector Weight
1 Healthcare 80.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTLT
51
DELISTED
CATALENT, INC.
CTLT
– –
-50,000
Closed -$2.82M
1 2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return
CIP
Castlefield Investment Partners Manchester $131M AUM

Sivik Global Healthcare's Q2 2024 Portfolio in Review

As of Q2 2024, Sivik Global Healthcare held 53 positions worth $278M, down 35% from $427M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Sivik Global Healthcare withdrew a net $149M in Q2 2024, closing 15 positions and reducing 16 holdings. Its most notable exit was State Street SPDR S&P Biotech ETF, an estimated $28.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, up from 58% a quarter earlier.

Against the trend, Sivik Global Healthcare opened a new position in Merck worth $8.15M.

  • Sivik Global Healthcare's largest Q2 2024 buy was Merck: 65,874 shares worth $8.15M.
  • Sivik Global Healthcare added most to Biogen in Q2 2024, an estimated $4.34M increase.
  • Sivik Global Healthcare's biggest Q2 2024 reduction was Humana, cutting an estimated $4.22M.
  • Sivik Global Healthcare fully exited State Street SPDR S&P Biotech ETF in Q2 2024, selling an estimated $28.5M.
  • Sivik Global Healthcare's ten largest holdings make up 51% of its $278M portfolio in Q2 2024.
  • Sivik Global Healthcare opened 6 new positions and closed 15 in Q2 2024.
  • Sivik Global Healthcare's portfolio value fell 35% quarter-over-quarter to $278M.

Based on Sivik Global Healthcare's 13F filing for Q2 2024, filed 29 Jul 2024.